DISCRIMINANT FUNCTION-ANALYSIS OF BODY-SURFACE POTENTIAL MAPS IN ACUTE MYOCARDIAL-INFARCTION

被引:4
作者
MCMECHAN, SR
CULLEN, CM
MACKENZIE, G
DEMPSEY, GJ
WRIGHT, GT
CRAWLEY, M
ANDERSON, J
ADGEY, AAJ
机构
[1] UNIV ULSTER, NO IRELAND BIOENGN CTR, JORDANSTOWN, NORTH IRELAND
[2] QUEENS UNIV BELFAST, DEPT EPIDEMIOL & PUBL HLTH, BELFAST, ANTRIM, NORTH IRELAND
关键词
MYOCARDIAL INFARCTION; BODY SURFACE MAPS; DISCRIMINANT FUNCTION ANALYSIS;
D O I
10.1016/S0022-0736(94)80068-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using a newly developed 64-electrode portable mapping device, QRS and ST-T isointegral maps were compared in 194 control subjects and 101 patients. One hundred ninety-four control subjects (mean age, 48 years; 120 men) with no history of cardiac disease were selected randomly and mapped. One hundred one patients (mean age, 62 years; 77 men) were mapped at presentation of chest pain suggestive of first myocardial infarction (MI); all patients had classic 12-lead electrocardiographic findings-46 with anterior and 55 with inferior MI. The diagnosis was confirmed in all cases by a significant rise in serial cardiac enzymes. The mean delay between onset of chest pain to map recording was 163 minutes. Of the 101 patients, 78 were first mapped outside the hospital. Applying discriminant function analysis to the isointegral measurements made on the control subjects and on the first map of MI patients achieved a correct classification of 97% of the control subjects (189 of 194) and 72% of the anterior (33 of 46) and 76% of the inferior (42 of 55) MI groups. This preliminary study suggests that discriminant function analysis, based on isointegral maps, not only provides a method of separating control subjects from MI patients but that it can also differentiate between types of infarct. Further studies are required to improve the predictive values of discriminant function and to extend the methodology to assess both the site and size of MI.
引用
收藏
页码:117 / 120
页数:4
相关论文
共 14 条
[11]  
RIPLEY BD, 1994, J R STAT SOC B, V56, P409
[12]   AN INTERNATIONAL RANDOMIZED TRIAL COMPARING 4 THROMBOLYTIC STRATEGIES FOR ACUTE MYOCARDIAL-INFARCTION [J].
TOPOL, E ;
CALIFF, R ;
VANDEWERF, F ;
ARMSTRONG, PW ;
AYLWARD, P ;
BARBASH, G ;
BATES, E ;
BETRIU, A ;
BOISSEL, JP ;
CHESEBRO, J ;
COL, J ;
DEBONO, D ;
GORE, J ;
GUERCI, A ;
HAMPTON, J ;
HIRSH, J ;
HOLMES, D ;
HORGAN, J ;
KLEIMAN, N ;
MARDER, V ;
MORRIS, D ;
OHMAN, M ;
PFISTERER, M ;
ROSS, A ;
RUTSCH, W ;
SADOWSKI, Z ;
SIMOONS, M ;
VAHANIAN, A ;
WEAVER, WD ;
WHITE, H ;
WILCOX, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (10) :673-682
[13]   WHICH PATIENTS BENEFIT MOST FROM EARLY THROMBOLYTIC THERAPY WITH INTRACORONARY STREPTOKINASE [J].
VERMEER, F ;
SIMOONS, ML ;
BAR, FW ;
TIJSSEN, JGP ;
VANDOMBURG, RT ;
SERRUYS, PW ;
VERHEUGT, FWA ;
RES, JCJ ;
DEZWAAN, C ;
VANDERLAARSE, A ;
KRAUSS, XH ;
LUBSEN, J ;
HUGENHOLTZ, PG .
CIRCULATION, 1986, 74 (06) :1379-1389
[14]   PREHOSPITAL-INITIATED VS HOSPITAL-INITIATED THROMBOLYTIC THERAPY - THE MYOCARDIAL-INFARCTION TRIAGE AND INTERVENTION TRIAL [J].
WEAVER, WD ;
CERQUEIRA, M ;
HALLSTROM, AP ;
LITWIN, PE ;
MARTIN, JS ;
KUDENCHUK, PJ ;
EISENBERG, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (10) :1211-1216